A. Rogers

发表

Bone mineral density and biochemical markers of bone turnover in aseptic loosening after total hip arthroplasty

R. Eastell, I. Stockley, J. Wilkinson, 2003, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

Establishing a reference range for bone turnover markers in young, healthy women.

R. Eastell, P. Garnero, K. Naylor, 2008, Bone.

Evaluation of urinary N-telopeptide of type I collagen measurements in the management of osteoporosis in clinical practice

R. Eastell, N. Peel, A. Rogers, 2013, Osteoporosis International.

Rapid and robust response of biochemical markers of bone formation to teriparatide therapy.

R. Eastell, E. McCloskey, P. Garnero, 2009, Bone.

Circulating estradiol and osteoprotegerin as determinants of bone turnover and bone density in postmenopausal women.

R. Eastell, D. Greenfield, R. Hannon, 2002, The Journal of clinical endocrinology and metabolism.

Circulating osteoprotegerin and receptor activator for nuclear factor kappaB ligand: clinical utility in metabolic bone disease assessment.

R. Eastell, A. Rogers, 2005, The Journal of clinical endocrinology and metabolism.

Biochemical Markers as Predictors of Rates of Bone Loss After Menopause

R. Eastell, R. Hannon, A. Rogers, 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Immediate changes in biochemical markers of bone turnover and circulating interleukin-6 after parathyroidectomy for primary hyperparathyroidism.

R. Eastell, B. Harrison, R. Hannon, 2000, European journal of endocrinology.

The effect of 17beta-estradiol on production of cytokines in cultures of peripheral blood.

R. Eastell, A. Rogers, 2001, Bone.

Effects of Estrogen Therapy of Postmenopausal Women on Cytokines Measured in Peripheral Blood

R. Eastell, A. Rogers, 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

A randomised, double-blinded, placebo-controlled, trial to determine the individual response in bone turnover markers to lasofoxifene therapy.

R. Eastell, A. Rogers, S. J. Glover, 2009, Bone.

Association between vitamin D receptor gene polymorphisms, falls, balance and muscle power: results from two independent studies (APOSS and OPUS)

D. Felsenberg, R. Eastell, D. Reid, 2010, Osteoporosis International.

Effects of raloxifene and alendronate on bone turnover as assessed by procollagen type I N-terminal propeptide

R. Eastell, J. Krege, A. Rogers, 2011, Osteoporosis International.

Serum osteoprotegerin as a determinant of bone metabolism in a longitudinal study of human pregnancy and lactation.

R. Eastell, K. Naylor, R. Fraser, 2003, The Journal of clinical endocrinology and metabolism.